422
Views
53
CrossRef citations to date
0
Altmetric
Original Article

Carbapenem resistant Klebsiella pneumoniae isolated from bloodstream infection: Indian experience

, , , , &

References

  • Parveen RM, Harish BN, Parija SC. Emerging carbapenem resistance among nosocomial isolates of Klebsiella pneumoniae in South India. Int J Pharma Biosci. 2010;1(2):1–11.
  • Johnson AP, Woodford N. Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistance. J Med Microbiol. 2013;62(4):499–513. 10.1099/jmm.0.052555-0
  • Sharma A, Bakthavatchalam YD, Gopi R, et al. Mechanisms of carbapenem resistance in K. pneumoniae and E. coli from bloodstream infections in India. J Infect Dis Ther. 2016;4:293.
  • Pragasam AK, Sahni RD, Anandan S, et al. A pilot study on carbapenemase detection: do we see the same level of agreement as with the CLSI Observations. J Clin Diagn Res. 2016;10(7):DC09.
  • Singh SK, Gupta M. blaOXA-48 carrying clonal colistin resistant-carbapenem resistant Klebsiella pneumoniae in neonate intensive care unit India. Microb Pathog. 2016;30(100):75–77. 10.1016/j.micpath.2016.09.009
  • Patel G, Huprikar S, Factor SH, et al. Outcomes of carbapenem-resistant klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol. 2008;29(12):1099–1106. 10.1086/592412
  • Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, et al. Predictors of carbapenem-resistant klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother. 2008;52(3):1028–1033. 10.1128/AAC.01020-07
  • Falagas ME, Rafailidis PI, Kofteridis D, et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case–control study. J Antimicrob Chemo. 2007;60(5):1124–1130. 10.1093/jac/dkm356
  • Daikos GL, Markogiannakis A. Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems? Clin Microbiol Infect. 2011;17(8):1135–1141. 10.1111/j.1469-0691.2011.03553.x
  • Ben-David D, Kordevani R, Keller N, et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect. 2012;18(1):54–60. 10.1111/j.1469-0691.2011.03478.x
  • Koshi M. Myer’s and Koshi’s manual of diagnostic procedures in medical microbiology and immunology/serology. Vellore, India: Christian Medical College and Hospital; 2001.
  • Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disc susceptibility testing; approved standard. 12th ed. CLSI document M02-A12. 35(1). Wayne (PA); 2015.
  • Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; twenty fifth informational supplement. Wayne (PA): Clinical and Laboratory Standards Institute. CLSI document; 2015. p. M100–S25.
  • Dallenne C, Da Costa A, Decré D, et al. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother. 2010;65(3):490–495.10.1093/jac/dkp498
  • Woodford N, Ward ME, Kaufmann ME, et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. J Antimicrob Chemother. 2004;54(4):735–743.10.1093/jac/dkh424
  • Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol. 2002;40(6):2153–2162.10.1128/JCM.40.6.2153-2162.2002
  • Poirel L, Walsh TR, Cuvillier V, et al. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119–123.10.1016/j.diagmicrobio.2010.12.002
  • Ellington MJ, Kistler J, Livermore DM, et al. Multiplex PCR for rapid detection of genes encoding acquired metallo-β-lactamases. J Antimicrob Chemother. 2007;59(2):321–322.
  • Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45(4):1151–1161.10.1128/AAC.45.4.1151-1161.2001
  • World Health Organization. Antimicrobial resistance: 2014 Global report on surveillance. World Health Organization; 2014.
  • Lee CR, Lee JH, Park KS, et al. Global dissemination of carbapenemase-producing Klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods. Front Microbiol. 2016;7.
  • Manoharan A, Premalatha K, Chatterjee S, et al. Correlation of TEM, SHV and CTX-M extended-spectrum beta lactamases among Enterobacteriaceae with their in vitro antimicrobial susceptibility. Indian J Med Microbiol. 2011;29(2):161.10.4103/0255-0857.81799
  • Goyal A, Prasad KN, Prasad A, et al. Extended spectrum β-lactamases in Escherichia coli & Klebsiella pneumoniae & associated risk factors. Indian J Med Res. 129(6):695–700.
  • Nagaraj S, Chandran SP, Shamanna P, et al. Carbapenem resistance among Escherichia coli and Klebsiella pneumoniae in a tertiary care hospital in south India. Indian J Med Microbiol. 2012;30(1):93.
  • Anandan S, Damodaran S, Gopi R, et al Rapid screening for carbapenem resistant organisms: current results and future approaches. J Clin Diagn Res: JCDR. 2015;9(9): DM01.
  • Falagas ME. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis J-CDC. 2014;20(7).
  • Veeraraghavan B, Shankar C, Vijayakumar S. Can minocycline be a carbapenem sparing antibiotic? current evidence. Indian J Med Microbiol. 2016;34(4):513.10.4103/0255-0857.195380
  • Pragasam AK, Shankar C, Veeraraghavan B, et al. Molecular mechanisms of colistin resistance in Klebsiella pneumoniae causing bacteremia from India – a first report. Front Microbiol. 2016;7:2135.
  • Halaby T, Kucukkose E, Janssen AB, et al. Genomic characterization of colistin heteroresistance in Klebsiella pneumoniae during a nosocomial outbreak. Antimicrob Agents Chemother. 2016;60(11):6837–6843.10.1128/AAC.01344-16
  • Neonakis IK, Samonis G, Messaritakis H, et al. Resistance status and evolution trends of Klebsiella pneumoniae isolates in a university hospital in Greece: ineffectiveness of carbapenems and increasing resistance to colistin. Chemotherapy. 2010;56:448–452. 10.1159/000320943
  • Kontopidou F, Plachouras D, Papadomichelakis E, et al. Colonization and infection by colistin-resistant Gram-negative bacteriain a cohort of critically ill patients. Clin Microbiol Infect. 2011;17:E9–E11. 10.1111/j.1469-0691.2011.03649.x
  • Liu YY, Wang Y, Walsh TR, et al Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161–168.10.1016/S1473-3099(15)00424-7
  • Xavier BB, Lammens C, Ruhal R, et al. Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium. Eurosurveillance. July 7,2016;21(27).
  • Qureshi ZA, Paterson DL, Potoski BA, et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother. 2012;56(4):2108–2113.10.1128/AAC.06268-11
  • Tumbarello M, Viale P, Viscoli C, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis. 2012;55(7):943–950. 10.1093/cid/cis588
  • Daikos GL, Tsaousi S, Tzouvelekis LS, et al. Carbapenemase-producing klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother. 2014;58(4):2322–2328. 10.1128/AAC.02166-13
  • Shankar C, Nabarro LE, Ragupathi NK, et al. Draft genome sequences of three hypervirulent carbapenem-resistant Klebsiella pneumoniae isolates from bacteremia. Genome Announcements. 2016;4(6):e01081–16.
  • Sharma J, Sharma M, Ray P. Detection of TEM & SHV genes in Escherichia coli & Klebsiella pneumoniae isolates in a tertiary care hospital from India. Indian J Med Res. 2010;132: 332–336.
  • Mohamudha PR, Harish BN, Parija SC. Molecular description of plasmid-mediated AmpC β-lactamases among nosocomial isolates of Escherichia coli & Klebsiella pneumoniae from six different hospitals in India. Indian J Med Res. 2012;135(1):114.
  • Krishnamurthy V, Vijaykumar GS, Kumar S, et al. Phenotypic and genotypic methods for detection of extended spectrum β lactamase producing Escherichia coli and Klebsiella pneumoniae isolated from ventilator associated pneumonia. J Clin Diagn Res: JCDR. 2013;7(9):1975.
  • Chaudhary M, Payasi A. Antimicrobial susceptibility patterns and molecular characterization of Klebsiella pneumoniae clinical isolates from north Indian patients. Int J Med Med Sci. 2013;46:1218–1224.
  • Roy S, Gaind R, Chellani H, et al. Neonatal septicaemia caused by diverse clones of Klebsiella pneumoniae & Escherichia coli harbouring blaCTX-M-15. Indian J Med Res. 2013;137(4):791.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.